Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Wuhan Kindstar Diagnostics Raises $20 Million for Testing Services

publication date: Mar 5, 2012
Wuhan Kindstar Diagnostics has raised $20 million in a C round from western investors. Kindstar will use the money to expand the esoteric testing services the company offers to China hospitals. It currently services over 2,000 hospitals in 320 cities located in every one of China’s provinces. The China arm of Kleiner Perkins Caufield & Byers contributed $16 million of the total. The remaining $4 million was raised from existing investors WI Harper Group and Baird Capital Partners Asia. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital